Provided by Tiger Trade Technology Pte. Ltd.

Tricida Inc.

0.1080
0.0000
Volume:- -
Turnover:3.19M
Market Cap:6.27M
PE:-0.05
High:0.1080
Open:0.1080
Low:0.1080
Close:0.1080
52wk High:13.85
52wk Low:0.0922
Shares:58.03M
Float Shares:50.89M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3524
EPS(LYR):-3.4431
ROE:-323.71%
ROA:-60.11%
PB:-0.05
PE(LYR):-0.03

Loading ...

Company Profile

Company Name:
Tricida Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of TRC101, a non-absorbed orally-administered polymer that has completed phase 3 trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California.